Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2010

Open Access 01-12-2010 | Research

A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma

Authors: Peng Guo-Qing, Yang Yuan, Zhong Cai-Gao, Yin Hongling, Hu Gonghua, Tian Yan

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2010

Login to get access

Abstract

Background

Human 8-oguanine glycosylase 1(hOGG1), voltage-dependent anion channel 1(VDAC1), hexokinase 2(HK-2), represented the process of oxidative DNA damage, cell apoptosis and glycolysis, respectively. This study aims to explore the association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma.

Methods

A case-control study was conducted. 65 cervical biopsy samples consist of 20 control and 45 cases. The expression of hOGG1, VDAC1 and HK-2 were examined with immunohistochemistry(IHC), immunolabeling was evaluated with stereological cell counts.

Results

The data showed that the positive proportion of hOGG1 and HK-2 in the case group was higher than that of the control group (P < 0.05). Further, there was an increasing trend for the positive proportion and expression degree of hOGG1 and HK-2 from Control, Mild cervical carcinoma (MCC), Intermediate cervical carcinoma(ICC) to Severe cervical carcinoma(SCC) in order (P < 0.05). To VDAC1, the significant result was not obtained.

Conclusions

The results suggested that there was a close association between expression of hOGG1, HK-2 and cervical cancer. hOGG1 and HK-2 might play a key role at the early stage of cervical cancer, and the findings of hOGG1 and HK-2 should be considered as a significant biomarker at the early stage of cervical cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parkin D Maxwell, Bray Freddie, Ferlay Jacques, Pisani Paola: Estimating the world burden: Globocan 2000[J]. Int J cancer. 2001, 94 (2): 153-156. 10.1002/ijc.1440.CrossRef Parkin D Maxwell, Bray Freddie, Ferlay Jacques, Pisani Paola: Estimating the world burden: Globocan 2000[J]. Int J cancer. 2001, 94 (2): 153-156. 10.1002/ijc.1440.CrossRef
2.
go back to reference Ding MA, Ling XI: Epidemiology and etiology research progress of Cervical Cancer. Journal of Practical Obstetrics and Gynecology. 2001, 17 (02): 61-62. Ding MA, Ling XI: Epidemiology and etiology research progress of Cervical Cancer. Journal of Practical Obstetrics and Gynecology. 2001, 17 (02): 61-62.
3.
go back to reference Russell JM, Blair V, Hunter RD: Cervical carcinoma: Prognosis in younger patients[J]. Br Med J. 1987, 295: 300-10.1136/bmj.295.6593.300.CrossRef Russell JM, Blair V, Hunter RD: Cervical carcinoma: Prognosis in younger patients[J]. Br Med J. 1987, 295: 300-10.1136/bmj.295.6593.300.CrossRef
4.
go back to reference Wenhua Zhang, Ping Bai, Shaokang Ma: Carcinoma of the cervix in younger women (≤ 35 year). Chinese Journal of Clinical Oncology and Rehabilitation. 1999, 6 (6): 39-41. Wenhua Zhang, Ping Bai, Shaokang Ma: Carcinoma of the cervix in younger women (≤ 35 year). Chinese Journal of Clinical Oncology and Rehabilitation. 1999, 6 (6): 39-41.
5.
go back to reference Elliott PM, Tattersall MH, Coppleson M, Russell P, Wong F, Coates AS, Solomon HJ, Bannatyne PM, Atkinson KH, Murray JC: Changing character of cervical cancer in young women[J]. Br Med J. 1989, 298 (2): 288-290. 10.1136/bmj.298.6669.288.CrossRef Elliott PM, Tattersall MH, Coppleson M, Russell P, Wong F, Coates AS, Solomon HJ, Bannatyne PM, Atkinson KH, Murray JC: Changing character of cervical cancer in young women[J]. Br Med J. 1989, 298 (2): 288-290. 10.1136/bmj.298.6669.288.CrossRef
6.
go back to reference Thomas DB, Ray RM, Qin Q: Risk factors for progression of squamous cell cervical carcinoma in-situ to invasive cervical cancer:results of a multinational study[J]. Cancer Causes Control. 2002, 13 (7): 683-690. 10.1023/A:1019527113057.CrossRef Thomas DB, Ray RM, Qin Q: Risk factors for progression of squamous cell cervical carcinoma in-situ to invasive cervical cancer:results of a multinational study[J]. Cancer Causes Control. 2002, 13 (7): 683-690. 10.1023/A:1019527113057.CrossRef
7.
go back to reference Ursin G, Pike MC, Preston-Martin S, d'Ablaing G, Peters RK: Sexual, reproductive and other risk factors for adenocarcinoma of the cervix, results from a population based control study(California, united states) [J]. Cancer Causes Control. 1996, 7 (3): 391-401. 10.1007/BF00052946.CrossRef Ursin G, Pike MC, Preston-Martin S, d'Ablaing G, Peters RK: Sexual, reproductive and other risk factors for adenocarcinoma of the cervix, results from a population based control study(California, united states) [J]. Cancer Causes Control. 1996, 7 (3): 391-401. 10.1007/BF00052946.CrossRef
8.
go back to reference CAO Ze-yi: The First Cervical Diseases Academic Conference of Chinese Medical Association. 2002, 36-39. CAO Ze-yi: The First Cervical Diseases Academic Conference of Chinese Medical Association. 2002, 36-39.
9.
go back to reference Reddy VG, Khanna N, Jain SK, Das BC, Singh N: Telomerase-A molecular marker for cervical cancer screening. Int J Gynecol Cancer. 2001, 11 (2): 100-106. 10.1046/j.1525-1438.2001.011001100.x.CrossRef Reddy VG, Khanna N, Jain SK, Das BC, Singh N: Telomerase-A molecular marker for cervical cancer screening. Int J Gynecol Cancer. 2001, 11 (2): 100-106. 10.1046/j.1525-1438.2001.011001100.x.CrossRef
10.
go back to reference Riethdorf S, Riethdorf L, Schulz G, Ikenberg H, Janicke F, Loning T, Park TW: Relationship between telomerase activation and HPV16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix. Int J Gynecol Pathol. 2001, 20 (2): 177-185. 10.1097/00004347-200104000-00011.CrossRef Riethdorf S, Riethdorf L, Schulz G, Ikenberg H, Janicke F, Loning T, Park TW: Relationship between telomerase activation and HPV16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix. Int J Gynecol Pathol. 2001, 20 (2): 177-185. 10.1097/00004347-200104000-00011.CrossRef
11.
go back to reference Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, Doeberitz MV: p16(1NK4a) immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Patho. 2002, 26 (11): 1389-1399. 10.1097/00000478-200211000-00001.CrossRef Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, Doeberitz MV: p16(1NK4a) immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Patho. 2002, 26 (11): 1389-1399. 10.1097/00000478-200211000-00001.CrossRef
12.
go back to reference Murphy N, Ring M, Heffron CCBB, King B, Killalea AG, Hughes C, Martin CM, McGuinness E, Sheils O, O'Leary JJ: p161NK4a, CDC6, and MCM5:predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. Clin Pathol. 2005, 58 (5): 525-534. 10.1136/jcp.2004.018895.CrossRef Murphy N, Ring M, Heffron CCBB, King B, Killalea AG, Hughes C, Martin CM, McGuinness E, Sheils O, O'Leary JJ: p161NK4a, CDC6, and MCM5:predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. Clin Pathol. 2005, 58 (5): 525-534. 10.1136/jcp.2004.018895.CrossRef
13.
go back to reference Cooke MS, Evans MD, Dizdaroglu M, Lunec J: Oxidative DNA damage: mechanisms, mutation and disease[J]. FASEB l. 2003, 17 (10): 1195-1214. 10.1096/fj.02-0752rev.CrossRef Cooke MS, Evans MD, Dizdaroglu M, Lunec J: Oxidative DNA damage: mechanisms, mutation and disease[J]. FASEB l. 2003, 17 (10): 1195-1214. 10.1096/fj.02-0752rev.CrossRef
14.
go back to reference Reed JC: Dysregulation of apoptosis in cancer. J Clin Oncol. 1999, 17: 2941-2953. Reed JC: Dysregulation of apoptosis in cancer. J Clin Oncol. 1999, 17: 2941-2953.
15.
go back to reference Gatenby RA, Gillies RJ: Why do cancers have high aerobic glycolysis?. Nature Reviews Cancer. 2004, 4 (11): 891-899. 10.1038/nrc1478.CrossRef Gatenby RA, Gillies RJ: Why do cancers have high aerobic glycolysis?. Nature Reviews Cancer. 2004, 4 (11): 891-899. 10.1038/nrc1478.CrossRef
16.
go back to reference Rosenquist TA, Zharkov DO, Grollman AP: Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase[J]. Proc Natl Acad Sci USA. 1997, 94 (14): 7429-7434. 10.1073/pnas.94.14.7429.CrossRef Rosenquist TA, Zharkov DO, Grollman AP: Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase[J]. Proc Natl Acad Sci USA. 1997, 94 (14): 7429-7434. 10.1073/pnas.94.14.7429.CrossRef
17.
go back to reference Ryerse J, Blachly-Dyson E, Forte M, Nagel B: Cloning and molecular characterization of a voltage-dependent anion-selective channel(VDAC) from Drosophila melanogaster. Biochim Biophys Acta. 1997, 1327 (2): 204-212. 10.1016/S0005-2736(97)00059-X.CrossRef Ryerse J, Blachly-Dyson E, Forte M, Nagel B: Cloning and molecular characterization of a voltage-dependent anion-selective channel(VDAC) from Drosophila melanogaster. Biochim Biophys Acta. 1997, 1327 (2): 204-212. 10.1016/S0005-2736(97)00059-X.CrossRef
18.
go back to reference Shinohara Y: Identification and characterization of hexokinase isozyme predominantly expressed in malignant tumor cells. Yakugaku Zasshi. 2000, 120 (8): 657-666. Shinohara Y: Identification and characterization of hexokinase isozyme predominantly expressed in malignant tumor cells. Yakugaku Zasshi. 2000, 120 (8): 657-666.
19.
go back to reference Dantzer F, Bjoras M, Luna L, Klungland A, Seeberg E: Comparative analysis of 8-oxoG: C, 8-oxoG: A, A:C and C:C DNA repair in extracts from wild type or 8-oxoG DNA glycosylase deficient mammalian and bacterial cells. DNA Repair. 2003, 2 (6): 707-718.CrossRef Dantzer F, Bjoras M, Luna L, Klungland A, Seeberg E: Comparative analysis of 8-oxoG: C, 8-oxoG: A, A:C and C:C DNA repair in extracts from wild type or 8-oxoG DNA glycosylase deficient mammalian and bacterial cells. DNA Repair. 2003, 2 (6): 707-718.CrossRef
20.
go back to reference Koukourakis MI, Pitiakoudis M, Giatromanolaki A, Tsarouha A, Polychronidis A, Sivridis E, Simopoulos C: Oxygen and glucose consumption in gastrointestinal adenocarcinomas: Correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Science. 2006, 97 (10): 1056-1060. 10.1111/j.1349-7006.2006.00298.x.CrossRef Koukourakis MI, Pitiakoudis M, Giatromanolaki A, Tsarouha A, Polychronidis A, Sivridis E, Simopoulos C: Oxygen and glucose consumption in gastrointestinal adenocarcinomas: Correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Science. 2006, 97 (10): 1056-1060. 10.1111/j.1349-7006.2006.00298.x.CrossRef
21.
go back to reference Golshani-Hebroni SG, Bessman SP: Hexokinase binding to mitochondria:a basis for proliferative energy metabolism[J]. J Bioenerg Biomembr. 1997, 29 (4): 331-338. 10.1023/A:1022442629543.CrossRef Golshani-Hebroni SG, Bessman SP: Hexokinase binding to mitochondria:a basis for proliferative energy metabolism[J]. J Bioenerg Biomembr. 1997, 29 (4): 331-338. 10.1023/A:1022442629543.CrossRef
22.
go back to reference Sun L, Shukair S, Naik TJ, Moazed F, Ardehali H: Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol Cell Biol. 2008, 28 (3): 1007-1017. 10.1128/MCB.00224-07.CrossRef Sun L, Shukair S, Naik TJ, Moazed F, Ardehali H: Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol Cell Biol. 2008, 28 (3): 1007-1017. 10.1128/MCB.00224-07.CrossRef
23.
go back to reference Pastorino JG, Shulga N, Hoek JB: Mitochondrial binding of hexokinse II inhibits Bax induced cytochrome c release and apoptosis. Journal of Biological Chemistry. 2002, 277: 7610-7618. 10.1074/jbc.M109950200.CrossRef Pastorino JG, Shulga N, Hoek JB: Mitochondrial binding of hexokinse II inhibits Bax induced cytochrome c release and apoptosis. Journal of Biological Chemistry. 2002, 277: 7610-7618. 10.1074/jbc.M109950200.CrossRef
Metadata
Title
A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma
Authors
Peng Guo-Qing
Yang Yuan
Zhong Cai-Gao
Yin Hongling
Hu Gonghua
Tian Yan
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2010
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-29-129

Other articles of this Issue 1/2010

Journal of Experimental & Clinical Cancer Research 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine